Advac Therapeutic LLC

Philadelphia, PA

UEI
JXDHQYNC4JQ9
CAGE
7Y4H5
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
Working Dog Center, 3401 Grays Ferry Ave Ste 1013 Bldg 176, Philadelphia, PA 19146, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of recombinant VSV vaccines for emerging bunyaviruses R41AI174426 National Institute of Allergy and Infectious Diseases (NIH) $787,623
Targeted delivery of novel mirna-based therapeutics for pneumonia-induced acute lung injury R41AI155327 National Institute of Allergy and Infectious Diseases (NIH) $880,078
Small-molecule combinationsexpand hematopoietic stem cell EX vivo and in vivo R41HL145877 National Heart Lung and Blood Institute (NIH) $609,705

Similar vendors

Vendor Location Primary NAICS
Soligenix, Inc. UEI GVD4XBVYD9J5 Princeton, NJ 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Sciogen LLC UEI RGEHAJ63EJK5 Los Altos, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Molecular Express, Inc. UEI R1JMHFESEKD5 Compton, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Covenant Therapeutics LLC UEI KKJLPNVZZWT2 Charlottesville, VA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Mirimus, Inc. UEI CP76MKEFKFE4 NY 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Advac Therapeutic LLC is registered to receive federal grant awards from the U.S. government. It is a partnership or limited liability partnership categorized as a minority-owned small disadvantaged business. Based on its past grant awards, Advac Therapeutic LLC appears to be a biotechnology company focused on developing vaccines and therapeutics for infectious diseases and regenerative medicine.

Advac Therapeutic LLC has received several federal grants from the National Institutes of Health (NIH), primarily through the National Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung, and Blood Institute (NHLBI). The grants awarded to Advac Therapeutic LLC include the development of recombinant vesicular stomatitis virus (rVSV) vaccines for emerging bunyaviruses like severe fever with thrombocytopenia syndrome virus (SFTSV), and the development of novel miRNA-based therapeutics for acute lung injury induced by bacterial pneumonia. Additionally, the company has received funding for research on small-molecule combinations to expand hematopoietic stem cells ex vivo and in vivo. The grant awards suggest that Advac Therapeutic LLC specializes in developing innovative vaccines, therapeutics, and regenerative medicine solutions for various infectious diseases and respiratory conditions.

Quick answers

Is Advac Therapeutic LLC registered in SAM.gov?

Yes. Advac Therapeutic LLC's SAM.gov registration is active through November 25, 2026.

What is Advac Therapeutic LLC's most recent federal award?

Advac Therapeutic LLC's most recent federal grant award is Development of recombinant VSV vaccines for emerging bunyaviruses (R41AI174426), from National Institute of Allergy and Infectious Diseases (NIH), on April 13, 2023.

On GovTribe

See Advac Therapeutic LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login